Age as a Risk Factor
Adolescents and young adults 16 through 21 years of age have higher rates of meningococcal disease. For this reason, the Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination of all persons 11 through 18 years of age with the meningococcal conjugate vaccine. Children 11-12 years of age should visit their health care providers to receive 1 dose of meningococcal vaccine and other preventive services. A booster dose of meningococcal vaccine is recommended at 16 years of age. Learn more about meningococcal vaccination.
To learn more about preteen and adolescent vaccines, visit the vaccine site.
Infants are also at higher risk for meningococcal disease. There are vaccines licensed to prevent meningococcal disease for children as young as 6 weeks of age, but they are only recommended for children with certain medical conditions or who are travelling to specific countries.
Questions and Answers for Parents about Meningitis and Vaccines [3 pages]
Ready-to-print versions of one of the CDC-reviewed Q&A material located on IAC's Vaccine Information web site (www.vaccineinformation.org) Dated 4/07
CDC’s Preteen Vaccine Campaign
Through extensive audience research, CDC has created posters, flyers, and PSAs in English and Spanish to educate parents and providers about preteen vaccines.
Meningococcal State Mandates for Elementary and Secondary Schools
Find out the meningococcal vaccination mandates for elementary and secondary schools in your state.
- Page last reviewed: April 1, 2014
- Page last updated: April 1, 2014
- Content source:
- Content source: National Center for Immunization and Respiratory Diseases